Louisiana State Employees Retirement System’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $258K | Hold |
31,700
| – | – | ﹤0.01% | 1483 |
|
2025
Q1 | $249K | Buy |
31,700
+5,600
| +21% | +$44K | ﹤0.01% | 1488 |
|
2024
Q4 | $389K | Hold |
26,100
| – | – | 0.01% | 1421 |
|
2024
Q3 | $399K | Sell |
26,100
-1,400
| -5% | -$21.4K | 0.01% | 1426 |
|
2024
Q2 | $419K | Buy |
27,500
+700
| +3% | +$10.7K | 0.01% | 1381 |
|
2024
Q1 | $506K | Sell |
26,800
-200
| -0.7% | -$3.78K | 0.01% | 1330 |
|
2023
Q4 | $516K | Sell |
27,000
-300
| -1% | -$5.73K | 0.01% | 1318 |
|
2023
Q3 | $490K | Sell |
27,300
-300
| -1% | -$5.39K | 0.01% | 1304 |
|
2023
Q2 | $561K | Buy |
27,600
+3,300
| +14% | +$67K | 0.01% | 1255 |
|
2023
Q1 | $443K | Sell |
24,300
-500
| -2% | -$9.12K | 0.01% | 1293 |
|
2022
Q4 | $513K | Hold |
24,800
| – | – | 0.01% | 1221 |
|
2022
Q3 | $649K | Buy |
24,800
+2,300
| +10% | +$60.2K | 0.02% | 1036 |
|
2022
Q2 | $645K | Buy |
22,500
+1,900
| +9% | +$54.5K | 0.02% | 1116 |
|
2022
Q1 | $644K | Buy |
+20,600
| New | +$644K | 0.02% | 1188 |
|